MMP9 and metabolic dysfunction-associated steatohepatitis: Two subgroups of NAFL patients and two subgroups of NASH patients could be distinguished based on their median MMP9 mRNA expression levels (9.97-fold and 16.25-fold mRNA expression level, respectively).